Ribosomal protein L16
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | ||
| + | <StructureSection load='1wki' size='350' side='right' scene='' caption='Ribosomal protein L16 (PDB code [[1wki]])'> | ||
== Function == | == Function == | ||
| Line 6: | Line 7: | ||
== Relevance == | == Relevance == | ||
Mutations in RPL16 confer reduced susceptibility to the antibiotic evernimicin<ref>PMID:10681347</ref>. | Mutations in RPL16 confer reduced susceptibility to the antibiotic evernimicin<ref>PMID:10681347</ref>. | ||
| - | + | </StructureSection> | |
== 3D Structures of Ribosomal protein L16 == | == 3D Structures of Ribosomal protein L16 == | ||
Revision as of 18:31, 29 September 2017
| |||||||||||
3D Structures of Ribosomal protein L16
Updated on 29-September-2017
References
- ↑ Nishimura M, Yoshida T, Shirouzu M, Terada T, Kuramitsu S, Yokoyama S, Ohkubo T, Kobayashi Y. Solution structure of ribosomal protein L16 from Thermus thermophilus HB8. J Mol Biol. 2004 Dec 10;344(5):1369-83. PMID:15561149 doi:10.1016/j.jmb.2004.10.011
- ↑ Adrian PV, Zhao W, Black TA, Shaw KJ, Hare RS, Klugman KP. Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action. Antimicrob Agents Chemother. 2000 Mar;44(3):732-8. PMID:10681347
